Sectra AB (SECT B):企業の財務・戦略的SWOT分析

◆英語タイトル:Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0049
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sectra AB (SECT B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sectra AB (Sectra) develops and sells technologies for medical systems and secure communication systems. Its operations are concentrated on two major sectors: Image IT Solutions and Secure Communications. The company’s subsidiary, Sectra Imaging IT Solutions AB, offers medical information technologies, with special expertise in digital image management and picture archiving systems for radiology, mammography, and bone densitometry. The company also develops and sells products for secure voice and data communications along with other customized systems through its subsidiary Sectra Communications AB. Sectra is headquartered in Linkoping, Sweden.

Sectra AB Key Recent Developments

Oct 30,2019: Sectra highlights amplified radiology efficiency at RSNA 2019
Oct 02,2019: Sectra extends its pre-operative orthopaedic solution with DePuy Synthes 3D templates
Sep 03,2019: Sectra’s three-month interim report 2019/2020: Successful initiatives in the US, now Sectra’s largest market
May 28,2019: Sectra: Order bookings doubled in the fourth quarter and operating profit up 15%
Mar 12,2019: Swedish healthcare providers secure communication with defense-level encrypted smartphones from Sectra

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sectra AB – Key Facts
Sectra AB – Key Employees
Sectra AB – Key Employee Biographies
Sectra AB – Key Operational Employees
Sectra AB – Major Products and Services
Sectra AB – History
Sectra AB – Company Statement
Sectra AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sectra AB – Business Description
Business Segment: Business Innovation
Overview
Financials
Business Segment: Imaging IT Solutions
Overview
Financials
Business Segment: Other Operations
Overview
Financials
Business Segment: Secure Communication Systems
Overview
Financials
Geographical Segment: Netherlands
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: UK
Performance
Geographical Segment: US
Performance
R&D Overview
Sectra AB – SWOT Analysis
SWOT Analysis – Overview
Sectra AB – Strengths
Sectra AB – Weaknesses
Sectra AB – Opportunities
Sectra AB – Threats
Sectra AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sectra AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Sectra AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Sectra AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 30, 2019: Sectra highlights amplified radiology efficiency at RSNA 2019
Oct 02, 2019: Sectra extends its pre-operative orthopaedic solution with DePuy Synthes 3D templates
Sep 03, 2019: Sectra’s three-month interim report 2019/2020: Successful initiatives in the US, now Sectra’s largest market
May 28, 2019: Sectra: Order bookings doubled in the fourth quarter and operating profit up 15%
Mar 12, 2019: Swedish healthcare providers secure communication with defense-level encrypted smartphones from Sectra
Mar 06, 2019: Sectra’s nine-month interim report 2018/2019: Sectra is growing with satisfied customers—tops ranking for sixth consecutive year
Jan 17, 2019: Sectra’s Capital Markets Day–focus on imaging IT solutions business area
Dec 20, 2018: Invitation to Sectra’s capital Markets Day 2019 – focus on medical imaging IT
Dec 07, 2018: Sectra’s six-month interim report 2018/2019: Stronger cash flow and increased order bookings in the US
Dec 04, 2018: Sectra enters the South Korean market by signing digital pathology distribution agreement with HuminTec
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sectra AB, Key Facts
Sectra AB, Key Employees
Sectra AB, Key Employee Biographies
Sectra AB, Key Operational Employees
Sectra AB, Major Products and Services
Sectra AB, History
Sectra AB, Subsidiaries
Sectra AB, Key Competitors
Sectra AB, Ratios based on current share price
Sectra AB, Annual Ratios
Sectra AB, Annual Ratios (Cont...1)
Sectra AB, Annual Ratios (Cont...2)
Sectra AB, Interim Ratios
Sectra AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Sectra AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Sectra AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sectra AB, Performance Chart (2015 - 2019)
Sectra AB, Ratio Charts
Sectra AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Sectra AB, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Sectra AB (SECT B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …
  • Fred’s Inc:企業の戦略・SWOT・財務情報
    Fred's Inc - Strategy, SWOT and Corporate Finance Report Summary Fred's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Petroleo Brasileiro SA (PETR4)-石油・ガス分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • Enercon Services Inc:電力:M&Aディール及び事業提携情報
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • Pharmaxis Ltd (PXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • University Hospitals:製薬・医療:M&Aディール及び事業提携情報
    Summary University Hospitals is a healthcare service provider that offers patient-centered medical care and education services. The center’s services include abdominal imaging, acupuncture, addiction recovery, advanced heart failure and transplant, bariatric surgery, behavioral pediatrics and psycho …
  • Amarin Corp Plc (AMRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of trigl …
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Manulife Holdings Berhad:企業の戦略・SWOT・財務情報
    Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AMEWAS, Inc.:企業の戦略・SWOT・財務情報
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pan Pacific Petroleum NL Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Ei Towers SpA:企業の戦略・SWOT・財務分析
    Ei Towers SpA - Strategy, SWOT and Corporate Finance Report Summary Ei Towers SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Valeo S.A.:企業の戦略・SWOT・財務情報
    Valeo S.A. - Strategy, SWOT and Corporate Finance Report Summary Valeo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Paychex, Inc.:企業の戦略・SWOT・財務情報
    Paychex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Paychex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Syros Pharmaceuticals Inc (SYRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medical Australia Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Medical Australia Ltd (Medical Australia), formerly BMDI TUTA Healthcare Pty Ltd is a medical device company that offers sterile and non-sterile medical plastics; wall suction, medical gas and suction pump products. The company's suction pumps include a range of mobile, portable and manual s …
  • JX Holdings, Inc.:企業の戦略・SWOT・財務情報
    JX Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JX Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆